Brief: EPO Grants Active Biotech's Patent Application For Eye Drop Formulation Of Laquinimod
23/10/2024 07:35
Oct 23 (Reuters) - Active Biotech AB publ ACTI.ST :
* EUROPEAN PATENT OFFICE HAS GRANTED ACTIVE BIOTECH’S PATENT
APPLICATION FOR EYE DROP FORMULATION OF LAQUINIMOD
Source text for Eikon: ID:nMFN3pRTdw
Further company coverage: ACTI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Active Biotech AB publ
See all newsBrief: Active Biotech Says Japan Grants Patent For Laquinimod Ophthalmic Formulation
Brief: Active Biotech Reports Q2 Operating Profit Of SEK -10.2 Mln
Brief: Active Biotech Expands U.S. Collaboration
Brief: Active Biotech Gets Approval To Resume Enrolment In Hovon 172 MF Study
Brief: Active Biotech Q1 Loss After Tax At SEK 8.4 Million